ZURICH & HAMBURG--(BUSINESS WIRE)--EBD Group, the leading partnering firm for the life science industry, will hold the 18th annual BIO-Europe® international partnering conference in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. The 2011 event boasted 14,765 scheduled one-to-one meetings with 3,565 licensing opportunities posted from among 1,596 companies that attended. Partnering remains the core drug development strategy of big pharma and biotech in the current economy. Pharma’s most high-dollar dealmakers of 2012 (including Abbott, AstraZeneca, and Merck) with deals valuing over USD 1 billion* are already confirmed to attend.
